News | AP VALVES & SH 2022

SAVR always better for younger AS? 'Durability data up to 10-years greenlights TAVR for patients between 65-70'

Long-term valve durability becomes crucial for younger AS populations; intermediate-term data strengthens case for TAVR in select patients under 70 years

News | AP VALVES & SH 2022

Data on TAVR-related stroke 'not enough, hard to justify routine EPD use except in BAV, ViVs,'

David J. Cohen, MD says field 'just not that good' at predicting TAVR-related stroke and its effects, but EPDs help patients with bicuspid valves, ViV procedures for now

News | AP VALVES & SH 2022

Not Just Alternative to SAVR: 'TAVR has become Standard of Treatment for Severe, Symptomatic AS'

AMC Heart Institute's Chairman Seung-jung Park, MD, PhD says 'For Tissue Valves, SAVR is Alternative to TAVR' in Severe, Symptomatic AS Patients Over 65 Years

News | AP VALVES & SH 2022

Promising New TAVR Techniques, Valves to Realize Ideal of '1 Procedure, 1 Valve' for Life

Eberhard Grube, MD Addresses THV Newcomers, Caveats in Evolving Field of TAVR at AP VALVES & SH 2022

News | AP VALVES & SH 2022

Celebrating 2 decades of TAVI: How 1 inventor, pioneer pushed heart history forward

Renowned French physician, interventional cardiologist Alain G. Cribier recognizes advancements, achievements of 20-year TAVI journey at AP VALVES & SH 2022

News | AP VALVES & SH 2021 Virtual

MITRA-FR vs. COAPT: Conflicting Results Harmonize to Deduce Ideal HF-FMR Patient for MitraClip

[AP VALVES & SH 2021] Insights gleaned from opposing MitraClip results help define optimal anatomical features for TEER

News | AP VALVES & SH 2021 Virtual

Data Hints at TAVR Expansion Into Low-risk Bicuspid AS but RCTs on Risky Morphology Still Missing

[AP VALVES & SH 2021] Cardiologists call for randomized trials defining morphology for positive TAVR outcomes in low surgical risk patients with bicuspid aortic stenosis